Work

Redox-responsive polymeric nanocarriers for targeted delivery of bruceantin to pancreatic cancer

Year: 2026
Type: article
Abstract: ). Biodistribution studies in an orthotopic pancreatic cancer murine model revealed substantial accumulation of LHRH-targeted nanoparticles primarily in tumors following systemic administration, with minimal hepatic deposition. Furthermore, BCT-loaded nanoplatforms reduced tumor growth by ∼72.4% relative to controls, with no detectable adverse effects. Collectively, this work highlights the potential of LHRH-functionalized nanoplatforms as a promising strategy for the targeted treatment of pancreatic cancer with BCT, offering enhanced therapeutic efficacy with minimal systemic toxicity and paving the way for future clinical translation of this natural product.
Source: Nanoscale
Language: English
Subfield: Biomaterials
Open Access status: green
OpenAlex ID: W7196948794
FWCI:
Cites: 52
Cited by:
Related to: 10